What does Canopus Biopharma, Inc. do?

Canopus Biopharma, Inc. (CBIA) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is CBIA's market cap?

Canopus Biopharma, Inc. (CBIA) has a market capitalization of approximately $455,071, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does CBIA pay a dividend?

No — Canopus Biopharma, Inc. (CBIA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

CBIA

Canopus Biopharma, Inc.

OTC·Medical, Pharmaceuticals · Healthcare

$0.00$0.00+0.00%

Market cap$455.07K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.87%CAGR −73.76%

Select date range

FromTo

Jun 24, 2008Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

CBIA does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$1.42M

Net Margin—

Operating Cash Flow−$159.18K

Capital Expenditures$0.00

Free Cash Flow−$159.18K

Return on Equity—

Return on Invested Capital17,766.8%

Net Debt$177.73K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for CBIA and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how CBIA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CBIA and 80,000+ other tickers.

About Canopus Biopharma, Inc.

Blue Heaven Coffee, Inc provides retail and digital advertising solutions. The company is based in Las Vegas, Nevada.

CEO: Patrick T. Prendergast
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: OTC
Employees: 72
Website: www.blueheaven.cafe

Peers

Peers Tab

CHIF

China Food and Beverage Company

Cap

$2.3K

PUGE

Puget Technologies, Inc.

Cap

$474.6K

CCWF

Church & Crawford, Inc.

Cap

$2.2M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About CBIA

What does Canopus Biopharma, Inc. do?: Canopus Biopharma, Inc. (CBIA) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is CBIA's market cap?: Canopus Biopharma, Inc. (CBIA) has a market capitalization of approximately $455,071, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does CBIA pay a dividend?: No — Canopus Biopharma, Inc. (CBIA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.